Business / Finance

RSS

HTA acquires 6 on-campus medical office buildings in South Florida

Healthcare Trust of America, Inc. "HTA") today announced it had acquired 6 on-campus medical office buildings ("MOB") located in South Florida for approximately $63 million.

23 Sep 2013

KaloBios Pharmaceuticals issues shares of common stock in underwritten public offering

KaloBios Pharmaceuticals, Inc. (KaloBios) today announced that it is offering to sell shares of its common stock in an underwritten public offering.

23 Sep 2013

Biolife Solutions to distribute SAVSU's precision thermal packaging products

BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and tissues, and contract aseptic media manufacturer, and SAVSU Technologies, Inc., a subsidiary of Barson Corporation, today jointly announced an agreement wherein BioLife will exclusively market and distribute SAVSU's proprietary precision thermal packaging products to the stem cells and regenerative medicine markets.

23 Sep 2013

Packaging Coordinators, Inc., to exhibit service offerings at CPhI 2013

Packaging Coordinators, Inc. (PCI), a global supplier of pharmaceutical commercial packaging solutions and clinical trials services is pleased to announce that it will be exhibiting its full range of services on booth 41M15 at CPhI Worldwide. Exhibiting for the first time as Packaging Coordinators, inc. since May 2013 when AndersonBrecon merged with and operated as Frazier Healthcare’s portfolio company, PCI, the company is now one of the largest suppliers of packaging supply services to the pharmaceutical industry and will be demonstrating its capabilities in clinical trials, in laboratory services and commercial services for pharmaceutical and biopharmaceutical customers.

From Packaging Coordinators Inc. (PCI) 23 Sep 2013

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Ablynx and AbbVie today announced that they have entered into a global license agreement to develop and commercialize the anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases.

23 Sep 2013

Veracyte files registration statement relating to proposed initial public offering of common stock

Veracyte, Inc. today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All of the shares to be sold in the proposed offering will be offered by Veracyte, Inc.

21 Sep 2013

Evolve IP announces that FirmTech joins its CloudNOW partner program

Evolve IP, The Cloud Services Company™, today announced that FirmTech has joined its CloudNOW partner program and is offering Evolve IP's award-winning virtual data centers/ servers, virtual desktops, and disaster recovery services to law offices in the Southern United States. Out of the gate, FirmTech was able to immediately identify business needs and implement solutions for several law firms.

21 Sep 2013

Skilled Healthcare announces funding of first loans insured by U.S. Department of HUD

Skilled Healthcare Group, Inc. (NYSE: SKH) today announced the funding of its first loans insured by the U.S. Department of Housing and Urban Development (HUD). The loans have a combined principal balance of $21.6 million and are secured by three skilled nursing facilities.

21 Sep 2013

Sanofi Opens Cancer Research Hub In Cambridge, MA

...

20 Sep 2013

BASF Eyes Strategic Protein Growth, Buys Verenium For $62M

...

20 Sep 2013

Verenium enters into definitive merger agreement with BASF

Verenium Corporation, a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced it has entered into a definitive merger agreement with BASF Corporation, a leading chemicals company, under which BASF will commence a cash tender offer for all of the outstanding shares of Verenium's common stock.

20 Sep 2013

Google Eyes Wider Healthcare Footprint With Tech-Focused Calico

...

19 Sep 2013

Agilent Marries Life-Sci And Diagnostics, On Eve Of Measurement Spinout

...

19 Sep 2013

Orbeshield Earns Soligenix Up To $26.3M From BARDA

...

19 Sep 2013

BARDA Exercises $6M Option For Aeolus' Acute Radiation Syndrome Drug

...

19 Sep 2013

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

...

19 Sep 2013

Inovalon, Walgreens sign agreement to bring innovative solutions to healthcare marketplace

Inovalon, Inc., a leading provider of data-driven healthcare solutions, and Walgreens, the nation's largest drugstore chain, today announced that they have entered into a multi-year agreement to provide Inovalon's data-driven encounter support platform, Electronic Patient Assessment Solution Suite within Healthcare Clinic at select Walgreens to support improvements in managed care quality and performance.

19 Sep 2013

Gentiva, Harden enter into definitive merger agreement

Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, and Harden Healthcare Holdings, Inc., a leading provider of home health, hospice and community care services, announced today that they have entered into a definitive merger agreement whereby Gentiva will acquire Harden.

19 Sep 2013

Ventana, Boehringer Ingelheim to develop companion diagnostic tests for oncology programs

Ventana Medical Systems, Inc., a member of the Roche Group, and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.

19 Sep 2013

CTI completes sale of 15,000 shares to Quogue Capital

Cell Therapeutics, Inc. today announced the closing of its previously announced sale of 15,000 shares of its Series 18 Preferred Stock directly to Quogue Capital LLC and an affiliate of Perceptive Advisors LLC in a registered direct offering conducted without an underwriter or placement agent for gross proceeds of approximately $15 million (the "Offering").

19 Sep 2013